Effect of celecoxib, a selective cyclooxygenase-2 inhibitor on carbon tetrachloride intoxication in rats

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 4, 2010, Pages 707-709

  Washino, Yukiko ^a   Koga, Eriko ^a   Kitamura, Yuko ^a   Kamikawa, Chiaki ^a   Kobayashi, Keiko ^a   Nakagawa, Tomoka ^a   Nakazaki, Chihiro ^a   Ichi, Ikuyo ^a   Kojo, Shosuke ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Ascorbic acid; Carbon tetrachloride; Celecoxib; Ceramide; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASCORBIC ACID; CARBON TETRACHLORIDE; CELECOXIB; CERAMIDE; CYCLOOXYGENASE 2 INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INTOXICATION; LIVER NECROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE POISONING; CERAMIDES; CYCLOOXYGENASE 2 INHIBITORS; DRUG-INDUCED LIVER INJURY; LIVER; MALE; NECROSIS; OXIDATIVE STRESS; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 77950904899     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.707     Document Type: Article

References (33)

1. Zimmerman H. J., "Hepatotoxicity, The Adverse Effects of Drugs and Other Chemicals on the Liver," Appleton-Century-Crofts, New York, 1978.
2. Edwards M. J., Keller B. J., Kauffman F. C., Thurman R. G., Toxicol. Appl. Pharmacol., 119, 275-279 (1993).
3. Ramadori G., Moriconi F., Malik I., Dudas J., J. Physiol. Pharmacol., 59 (Suppl. 1), 107-117 (2008).
4. Ryu A., Itabe H., Mutoh M., Kudo I., Arai H., Inoue K., J. Health Sci., 46, 275-281 (2000).
5. Basu S., Toxicology, 189, 113-127 (2003).
6. Kim S.-H., Cheon H. J., Yun N., Oh S.-T., Shin E., Shim K. S., Lee S.-M., J. Pharmacol. Sci., 109, 119-127 (2009).
7. Lee C.-H., Park S.-W., Kim Y. S., Kang S. S., Kim J. A., Lee S. H., Lee S.-M., Biol. Pharm. Bull., 30, 1898-1904 (2007).
8. Bhave V. S., Donthamsetty S., Latendresse J. R., Mehendale H. M., Toxicol. Appl. Pharmacol., 228, 239-246 (2008).
9. Soloviev V., Hassan A. N., Akatov V., Lezhnev E., Ghaffar T. Y., Ghaffar Y. A., Int. J. Artif. Organs, 26, 735-742 (2003).
10. Laleman W., Wilmer A., Evenepoel P., Verslype C., Fevery J., Nevens F., Aliment. Pharmacol. Ther., 23, 351-363 (2006).
11. Yamaguchi M., Miyashita Y., Kumagai Y., Kojo S., Bioorg. Med. Chem. Lett., 14, 4061-4064 (2004).
12. Ichi I., Nakahara K., Fujii K., Iida C., Miyashita Y., Kojo S., J. Nutr. Sci. Vitaminol., 53, 53-56 (2007).
13. Ichi I., Kamikawa C., Nakagawa T., Kobayashi K., Kataoka R., Nagata E., Kitamura Y., Nakazaki C., Matsura T., Kojo S., Toxicology, 261, 33-40 (2009).
14. Hannun Y. A., Obeid L. M., J. Biol. Chem., 277, 25847-25850 (2002).
15. Sun F., Tsutsui C., Hamagawa E., Ono Y., Ogiri Y., Kojo S., Biochim. Biophys. Acta, 1535, 186-191 (2001).
16. Kishida E., Nishimoto Y., Kojo S., Anal. Chem., 64, 1505-1507 (1992).
17. Yamada Y., Kajiwara K., Yano M., Kishida E., Masuzawa Y., Kojo S., Biochim. Biophys. Acta, 1532, 115-120 (2001).
18. Kojo S., Curr. Med. Chem., 11, 1041-1064 (2004).
19. Sun F., Hayami S., Ogiri Y., Haruna S., Tanaka K., Yamada Y., Tokumaru S., Kojo S., Biochim. Biophys. Acta, 1500, 181-185 (2000).
20. Sun F., Hamagawa E., Tsutsui C., Sakaguchi N., Kakuta Y., Tokumaru S., Kojo S., Biochem. Pharmacol., 65, 101-107 (2003).
21. Iida C., Fujii K., Koga E., Washino Y., Kitamura Y., Ichi I., Abe K., Matsura T., Kojo S., Arch. Toxicol., 83, 477-483 (2009).
22. Czaja M. J., Flanders K. C., Biempica L., Klein C., Zern M. A., Weiner F. R., Growth Factors, 1, 219-226 (1989).
23. Basu S., Biochem. Biophys. Res. Commun., 254, 764-767 (1999).
24. Czaja M. J., Xu J., Alt E., Gastroenterology, 108, 1849-1854 (1995).
25. Ferreri N. R., An S.-J., McGiff J. C., Am. J. Physiol., 277, F360-F368 (1999).
26. Yu J., Ip E., dela Pena A., Hou J. Y., Sesha J., Pera N., Hall P., Kirsch R., Leclercq I., Farrell G. C., Hepatology, 43, 826-836 (2006).
27. Yu J., Hui A. Y., Chu E. S., Cheng A. S., Go M. Y., Chan H. L., Leung W. K., Cheung K. F., Ching A. K., Chui Y. L., Chan K. K., Sung J. J., Gut, 56, 991-999 (2007).
28. Bhave V. S., Donthamsetty S., Latendresse J. R., Muskhelishvili L., Mehendale H. M., Toxicol. Appl. Pharmacol., 228, 225-238 (2008).
29. Planaguma A., Claria J., Miquel R., Lopez-Parra M., Titos E., Masferrer J. L., Arroyo V., Rodes J., FASEB J., 19, 1120-1122 (2005).
30. Horrillo R., Planaguma A., Gonzalez-Periz A., Ferre N., Titos E., Miquel R., Lopez-Parra M., Masferrer J. L., Arroyo V., Claria, J., J. Pharmacol. Exp. Ther., 323, 778-786 (2007).
31. Tu C.-T., Guo J.-S., Wang M., Wang J.-Y., J. Gastroenterol. Hepatol., 22, 877-884 (2007).
32. Hui A. Y., Leung W. K., Chan H. L. Y., Chan F. K. L., Go M. Y. Y., Chan K. K., Tang B. D., Chu E. S. H., Sung J. J. Y., Liver Int., 26, 125-146 (2006).
33. Schiffmann S., Sandner J., Schmidt R., Birod K., Wobst I., Schmidt H., Angioni C., Geisslinger G., Groesch S., J. Lipid Res., 50, 32-40 (2009).